Notch1 promotes hepatitis B virus X protein-induced hepatocarcinogenesis via Wnt/β-catenin pathway

International Journal of Oncology

Volumn 45, Issue 4, 2014, Pages 1638-1648

  Sun, Qian ^a,b   Wang, Ronghua ^a   Luo, Jing ^a   Wang, Peng ^a   Xiong, Si ^a   Liu, Man ^a   Cheng, Bin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

Hepatitis B virus X protein; Hepatocarcinogenesis; Notch1; Wnt catenin pathway

Indexed keywords

BETA CATENIN; HEPATITIS B VIRUS X PROTEIN; NOTCH1 RECEPTOR; SHORT HAIRPIN RNA; WNT PROTEIN; FRIZZLED PROTEIN; FZD10 PROTEIN, HUMAN; NOTCH1 PROTEIN, HUMAN; NOTCH1 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL; MALE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WNT SIGNALING PATHWAY; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; GENE SILENCING; GENETICS; HEPATITIS B VIRUS; LIVER; LIVER TUMOR; METABOLISM; PATHOLOGY; VIROLOGY; VIRUS CELL TRANSFORMATION;

ANIMALS; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, VIRAL; FRIZZLED RECEPTORS; GENE KNOCKDOWN TECHNIQUES; HEPATITIS B VIRUS; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; RECEPTOR, NOTCH1; TRANS-ACTIVATORS; WNT SIGNALING PATHWAY;

EID: 84907474252     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2537     Document Type: Article

References (36)

1. Block TM, Mehta AS, Fimmel CJ and Jordan R: Molecular viral oncology of hepatocellular carcinoma. Oncogene 22: 5093-5107, 2003. (Pubitemid 37059591)
2. Martin-Vilchez S, Lara-Pezzi E, Trapero-Marugan M, Moreno-Otero R and Sanz-Cameno P: The molecular and pathophysiological implications of hepatitis B X antigen in chronic hepatitis B virus infection. Rev Med Virol 21: 315-329, 2011.
3. Diao J, Garces R and Richardson CD: X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev 12: 189-205, 2001. (Pubitemid 32588145)
4. Wang F, Zhou H, Xia X, Sun Q, Wang Y and Cheng B: Activated Notch signaling is required for hepatitis B virus X protein to promote proliferation and survival of human hepatic cells. Cancer Lett 298: 64-73, 2010.
5. Wang F, Zhou H, Yang Y, Xia X, Sun Q, Luo J and Cheng B: Hepatitis B virus X protein promotes the growth of hepatocellular carcinoma by modulation of the Notch signaling pathway. Oncol Rep 27: 1170-1176, 2012.
6. Luo J, Zhou H, Wang F, Xia X, Sun Q, Wang R and Cheng B: The hepatitis B virus X protein downregulates NF-κB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells. Int J Oncol 42: 1636-1643, 2013.
7. Wang F, Xia X, Wang J, Sun Q, Luo J and Cheng B: Notch1 signaling contributes to the oncogenic effect of HBx on human hepatic cells. Biotechnol Lett 35: 29-37, 2013.
8. Sun Q, Wang R, Wang Y, Luo J, Wang P and Cheng B: Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma. Oncol Rep 31: 933-939, 2014.
9. Kopan R and Ilagan MX: The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137: 216-233, 2009.
10. Kopan R: Notch signaling. Cold Spring Harb Perspect Biol 4: pii: a011213, 2012.
11. Kalaitzidis D and Armstrong SA: Cancer: the flipside of Notch. Nature 473: 159-160, 2011.
12. Ranganathan P, Weaver KL and Capobianco AJ: Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 11: 338-351, 2011.
13. Giovannini C, Gramantieri L, Chieco P, et al: Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism. J Hepatol 50: 969-979, 2009.
14. Villanueva A, Alsinet C, Yanger K, et al: Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice. Gastroenterology 143: 1660-1669 e1667, 2012.
15. Qi R, An H, Yu Y, et al: Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res 63: 8323-8329, 2003. (Pubitemid 37549485)
16. Wang C, Qi R, Li N, et al: Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression. J Biol Chem 284: 16183-16190, 2009.
17. Viatour P, Ehmer U, Saddic LA, et al: Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway. J Exp Med 208: 1963-1976, 2011.
18. Zimmerman ZF, Moon RT and Chien AJ: Targeting Wnt pathways in disease. Cold Spring Harb Perspect Biol 4: pii: a008086, 2012.
19. Zhou J, Cheng P, Youn JI, Cotter MJ and Gabrilovich DI: Notch and wingless signaling cooperate in regulation of dendritic cell differentiation. Immunity 30: 845-859, 2009.
20. Camps J, Pitt JJ, Emons G, et al: Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/beta-catenin pathway in colorectal cancer. Cancer Res 73: 2003-2013, 2013.
21. Li C, Zhang Y, Lu Y, Cui Z, Yu M, Zhang S and Xue X: Evidence of the cross talk between Wnt and Notch signaling pathways in non-small-cell lung cancer (NSCLC): Notch3-siRNA weakens the effect of LiCl on the cell cycle of NSCLC cell lines. J Cancer Res Clin Oncol 137: 771-778, 2011.
22. Liao C, Zhao M, Song H, Uchida K, Yokoyama KK and Li T: Identification of the gene for a novel liver-related putative tumor suppressor at a high-frequency loss of heterozygosity region of chromosome 8p23 in human hepatocellular carcinoma. Hepatology 32: 721-727, 2000.
23. Cheng B, Zheng Y, Guo X, Wang Y and Liu C: Hepatitis B viral X protein alters the biological features and expressions of DNA repair enzymes in LO2 cells. Liver Int 30: 319-326, 2010.
24. Ueno K, Hirata H, Hinoda Y and Dahiya R: Frizzled homolog proteins, microRNAs and Wnt signaling in cancer. Int J Cancer 132: 1731-1740, 2013.
25. Terasaki H, Saitoh T, Shiokawa K and Katoh M: Frizzled-10, up-regulated in primary colorectal cancer, is a positive regulator of the WNT - beta-catenin - TCF signaling pathway. Int J Mol Med 9: 107-112, 2002.
26. Nagayama S, Yamada E, Kohno Y, et al: Inverse correlation of the up-regulation of FZD10 expression and the activation of beta-catenin in synchronous colorectal tumors. Cancer Sci 100: 405-412, 2009.
27. Gugger M, White R, Song S, Waser B, Cescato R, Riviere P and Reubi JC: GPR87 is an overexpressed G-protein coupled receptor in squamous cell carcinoma of the lung. Dis Markers 24: 41-50, 2008. (Pubitemid 350174569)
28. Nagayama S, Fukukawa C, Katagiri T, et al: Therapeutic potential of antibodies against FZD 10, a cell-surface protein, for synovial sarcomas. Oncogene 24: 6201-6212, 2005. (Pubitemid 43080043)
29. Fukukawa C, Hanaoka H, Nagayama S, et al: Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10. Cancer Sci 99: 432-440, 2008. (Pubitemid 351228502)
30. Merle P, de la Monte S, Kim M, et al: Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma. Gastroenterology 127: 1110-1122, 2004. (Pubitemid 39345880)
31. Bengochea A, de Souza MM, Lefrancois L, et al: Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer 99: 143-150, 2008. (Pubitemid 351920222)
32. Merle P, Kim M, Herrmann M, et al: Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma. J Hepatol 43: 854-862, 2005. (Pubitemid 41414512)
33. King TD, Zhang W, Suto MJ and Li Y: Frizzled7 as an emerging target for cancer therapy. Cell Signal 24: 846-851, 2012.
34. Nambotin SB, Lefrancois L, Sainsily X, et al: Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinoma. J Hepatol 54: 288-299, 2011.
35. Hsieh A, Kim HS, Lim SO, Yu DY and Jung G: Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/beta-catenin signaling. Cancer Lett 300: 162-172, 2011.
36. Cha MY, Kim CM, Park YM and Ryu WS: Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells. Hepatology 39: 1683-1693, 2004.